4
Changes in Ownership
Cardiff Oncology, Inc. Filed Acc 0000950170-25-038708
Options or other derivatives
- Chief Financial Officer acquired 332,621 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Levine James E. Chief Financial Officer | 2025-03-11 | Grant or award · Stock Options | +332,621 | 1,295,117 | D | ||
Loading xslF345X05/ownership.xml…